Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för William J Peters. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att William J Peters har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:AMPH / Amphastar Pharmaceuticals, Inc. | CFO, EVP & TREASURER, Director | 124 985 |
US:HITK / Hi-Tech Pharmacal Co. | EVP & Chief Financial Officer | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av William J Peters. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp AMPH / Amphastar Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i AMPH / Amphastar Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i AMPH / Amphastar Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av William J Peters som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −273 | 124 985 | −0,22 | 24,79 | −6 768 | 3 098 378 | |
2025-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −3 004 | 125 258 | −2,34 | 27,69 | −83 181 | 3 468 394 | |
2025-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 968 | 128 262 | −1,51 | 26,66 | −52 467 | 3 419 465 | |
2025-03-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 36 747 | 130 230 | 39,31 | ||||
2025-03-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 141 | 93 483 | −2,24 | 28,32 | −60 633 | 2 647 439 | |
2025-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 739 | 95 624 | −1,79 | 27,62 | −48 031 | 2 641 135 | |
2025-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −4 231 | 97 363 | −4,16 | 27,54 | −116 515 | 2 681 231 |
2025-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 490 | 101 594 | 7,96 | 13,35 | 99 992 | 1 356 280 | |
2024-11-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −7 426 | 94 103 | −7,31 | 52,05 | −386 523 | 4 898 061 |
2024-11-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 7 426 | 101 529 | 7,89 | 13,03 | 96 761 | 1 322 923 | |
2024-08-02 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 282 | 94 103 | −9,85 | 44,23 | −454 773 | 4 162 176 |
2024-08-02 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 282 | 104 385 | 10,93 | 20,23 | 208 005 | 2 111 709 | |
2024-06-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −635 | 94 103 | −0,67 | 41,29 | −26 222 | 3 885 946 |
2024-06-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −2 961 | 94 738 | −3,03 | 40,85 | −120 947 | 3 869 735 |
2024-05-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −387 | 97 268 | −0,40 | 43,48 | −16 827 | 4 229 213 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 255 | 97 655 | −4,18 | 43,05 | −183 178 | 4 204 048 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −5 105 | 101 910 | −4,77 | 43,05 | −219 770 | 4 387 226 | |
2024-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 285 | 107 015 | −2,09 | 43,05 | −98 369 | 4 606 996 | |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 190 | 109 300 | −1,96 | 46,31 | −101 419 | 5 061 683 | |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −51 | 111 490 | −0,05 | 48,00 | −2 448 | 5 351 520 |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −4 681 | 111 541 | −4,03 | 46,98 | −219 896 | 5 239 772 |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −13 404 | 116 222 | −10,34 | 46,30 | −620 540 | 5 380 509 |
2024-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 8 826 | 129 626 | 7,31 | 11,33 | 99 999 | 1 468 663 | |
2024-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 19 440 | 120 800 | 19,18 | ||||
2023-11-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −14 868 | 101 360 | −12,79 | 56,53 | −840 548 | 5 730 286 |
2023-11-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −30 162 | 116 228 | −20,60 | 55,67 | −1 679 203 | 6 470 738 |
2023-11-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −14 220 | 146 390 | −8,85 | 54,76 | −778 724 | 8 016 697 |
2023-11-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 38 000 | 160 610 | 30,99 | 13,03 | 495 140 | 2 092 748 | |
2023-11-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 21 250 | 122 610 | 20,96 | 20,23 | 429 888 | 2 480 400 | |
2023-09-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −59 | 101 360 | −0,06 | 52,26 | −3 083 | 5 297 134 |
2023-09-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −60 684 | 101 419 | −37,44 | 51,75 | −3 140 112 | 5 247 957 |
2023-09-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 25 250 | 162 103 | 18,45 | 13,03 | 329 008 | 2 112 202 | |
2023-09-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 21 250 | 136 853 | 18,38 | 20,23 | 429 888 | 2 768 536 | |
2023-09-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 115 603 | 9,47 | 19,79 | 197 900 | 2 287 783 | |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −13 000 | 105 603 | −10,96 | 52,79 | −686 270 | 5 574 782 |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −12 000 | 118 603 | −9,19 | 50,79 | −609 480 | 6 023 846 |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −11 868 | 130 603 | −8,33 | 48,79 | −579 040 | 6 372 120 |
2023-06-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 36 868 | 142 471 | 34,91 | 19,79 | 729 618 | 2 819 501 | |
2023-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −11 000 | 105 603 | −9,43 | 46,35 | −509 859 | 4 894 784 |
2023-06-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 11 000 | 116 603 | 10,42 | 13,35 | 146 850 | 1 556 650 | |
2023-05-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −378 | 104 770 | −0,36 | 44,16 | −16 692 | 4 626 643 | |
2023-05-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 500 | 105 148 | −9,08 | 44,35 | −465 675 | 4 663 314 |
2023-05-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 500 | 115 648 | 9,99 | 13,35 | 140 175 | 1 543 901 | |
2023-04-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −5 632 | 105 148 | −5,08 | 42,35 | −238 515 | 4 453 018 |
2023-04-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 5 632 | 110 780 | 5,36 | 13,35 | 75 187 | 1 478 913 | |
2023-04-14 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −4 868 | 105 148 | −4,42 | 42,35 | −206 160 | 4 453 018 |
2023-04-14 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 4 868 | 110 016 | 4,63 | 13,35 | 64 988 | 1 468 714 | |
2023-04-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 032 | 105 148 | −8,71 | 40,35 | −404 791 | 4 242 722 |
2023-04-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 032 | 115 180 | 9,54 | 13,35 | 133 927 | 1 537 653 | |
2023-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 162 | 105 148 | −3,81 | 36,29 | −151 039 | 3 815 821 | |
2023-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 995 | 109 310 | −4,37 | 37,60 | −187 812 | 4 110 056 | |
2023-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 146 | 114 305 | −3,50 | 36,84 | −152 739 | 4 210 996 | |
2023-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −12 776 | 118 451 | −9,74 | 36,43 | −465 472 | 4 315 561 |
2023-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 6 688 | 131 227 | 5,37 | 14,95 | 99 986 | 1 961 844 | |
2023-03-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 23 925 | 124 539 | 23,78 | ||||
2023-03-03 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 974 | 100 614 | −9,83 | 36,33 | −398 685 | 3 655 307 |
2023-03-03 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 974 | 111 588 | 10,91 | 11,33 | 124 335 | 1 264 292 | |
2022-08-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 100 480 | −9,05 | 38,35 | −383 500 | 3 853 408 |
2022-08-10 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 110 480 | 9,95 | 13,35 | 133 500 | 1 474 908 | |
2022-07-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −18 386 | 100 480 | −15,47 | 34,95 | −642 591 | 3 511 776 |
2022-07-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 18 386 | 118 866 | 18,30 | 14,95 | 274 871 | 1 777 047 | |
2022-06-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −5 512 | 100 480 | −5,20 | 32,05 | −176 682 | 3 220 786 |
2022-05-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −378 | 104 609 | −0,36 | 33,70 | −12 739 | 3 525 323 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 162 | 104 987 | −3,81 | 34,18 | −142 257 | 3 588 456 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −50 777 | 0 | −100,00 | ||||
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 995 | 109 149 | −4,38 | 34,22 | −170 929 | 3 735 079 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −3 760 | 114 144 | −3,19 | 34,36 | −129 197 | 3 922 091 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −47 017 | 117 904 | −28,51 | 33,93 | −1 595 230 | 4 000 341 | |
2022-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 50 777 | 164 921 | 44,49 | 14,40 | 731 189 | 2 374 862 | |
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 50 743 | 50 743 | |||||
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −5 989 | 114 144 | −4,99 | 34,74 | −208 058 | 3 965 363 | |
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 21 991 | 120 133 | 22,41 | ||||
2022-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −7 900 | 98 142 | −7,45 | 34,46 | −272 248 | 3 382 150 |
2022-03-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −13 026 | 59 522 | −17,96 | ||||
2022-03-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −13 026 | 106 042 | −10,94 | 29,35 | −382 313 | 3 112 333 |
2022-03-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 13 026 | 119 068 | 12,28 | 13,35 | 173 897 | 1 589 558 | |
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −23 000 | 25 074 | −47,84 | ||||
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −12 000 | 106 042 | −10,17 | 28,95 | −347 400 | 3 069 916 |
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −11 000 | 118 042 | −8,52 | 27,95 | −307 450 | 3 299 274 |
2022-03-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 23 000 | 129 042 | 21,69 | 14,95 | 343 850 | 1 929 178 | |
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 48 074 | −17,22 | ||||
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 106 042 | −8,62 | 26,95 | −269 500 | 2 857 832 |
2022-02-09 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 116 042 | 9,43 | 14,95 | 149 500 | 1 734 828 | |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −16 000 | 50 777 | −23,96 | ||||
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −16 000 | 106 042 | −13,11 | 25,40 | −406 400 | 2 693 467 |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 16 000 | 122 042 | 15,09 | 14,40 | 230 400 | 1 757 405 | |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −31 776 | 66 777 | −32,24 | ||||
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −11 776 | 106 042 | −10,00 | 24,90 | −293 222 | 2 640 446 |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −20 000 | 117 818 | −14,51 | 24,15 | −483 000 | 2 845 305 |
2022-01-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 31 776 | 137 818 | 29,97 | 14,40 | 457 574 | 1 984 579 | |
2022-01-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 98 553 | −9,21 | ||||
2022-01-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 106 042 | −8,62 | 23,40 | −234 000 | 2 481 383 |
2022-01-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 116 042 | 9,43 | 14,40 | 144 000 | 1 671 005 | |
2021-12-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −8 256 | 108 553 | −7,07 | ||||
2021-12-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −8 256 | 106 042 | −7,22 | 22,40 | −184 934 | 2 375 341 |
2021-12-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 8 256 | 114 298 | 7,79 | 14,40 | 118 886 | 1 645 891 | |
2021-12-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −1 744 | 116 809 | −1,47 | ||||
2021-12-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 744 | 106 042 | −1,62 | 22,40 | −39 066 | 2 375 341 |
2021-12-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 1 744 | 107 786 | 1,64 | 14,40 | 25 114 | 1 552 118 | |
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 19 800 | −33,56 | ||||
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 105 689 | −8,64 | 21,33 | −213 300 | 2 254 346 |
2021-11-12 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 115 689 | 9,46 | 11,33 | 113 300 | 1 310 756 | |
2021-08-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −6 589 | 105 689 | −5,87 | 19,35 | −127 524 | 2 045 515 |
2021-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 29 800 | −25,13 | ||||
2021-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −10 000 | 112 278 | −8,18 | 20,37 | −203 739 | 2 287 541 | |
2021-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 122 278 | 8,91 | 11,33 | 113 300 | 1 385 410 | |
2021-05-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 7 209 | 7 209 | |||||
2021-05-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 3 047 | 111 349 | 2,81 | ||||
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 78 833 | 78 833 | |||||
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 33 574 | 108 302 | 44,93 | ||||
2021-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −6 398 | 74 728 | −7,89 | 18,44 | −117 979 | 1 377 984 | |
2021-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 178 | 81 | −98,10 | 19,15 | −80 009 | 1 554 | |
2021-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −4 244 | 85 304 | −4,74 | 19,03 | −80 745 | 1 622 968 |
2021-01-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −6 495 | 89 548 | −6,76 | 18,67 | −121 237 | 1 671 521 |
2020-08-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −5 512 | 95 652 | −5,45 | 20,36 | −112 223 | 1 947 456 |
2020-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 39 800 | −20,08 | ||||
2020-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −13 656 | 101 164 | −11,89 | 22,00 | −300 405 | 2 225 406 |
2020-07-08 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 114 820 | 9,54 | 11,33 | 113 300 | 1 300 911 | |
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −3 434 | 104 038 | −3,20 | 14,50 | −49 793 | 1 508 551 | |
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 94 350 | 94 350 | |||||
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 40 291 | 107 472 | 59,97 | ||||
2020-03-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 915 | 67 181 | −4,16 | 13,03 | −37 982 | 875 368 | |
2020-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 178 | 70 096 | −5,63 | 14,19 | −59 286 | 994 662 | |
2020-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 737 | 74 274 | −2,29 | 14,43 | −25 058 | 1 071 484 |
2020-03-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −2 964 | 76 011 | −3,75 | 13,66 | −40 481 | 1 038 113 |
2020-01-23 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 990 | 78 975 | −4,81 | 20,07 | −80 071 | 1 584 855 |
2019-09-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −9 800 | 49 800 | −16,44 | ||||
2019-09-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −9 800 | 82 453 | −10,62 | 21,76 | −213 256 | 1 794 243 |
2019-09-18 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 9 800 | 92 253 | 11,89 | 11,33 | 111 034 | 1 045 226 | |
2019-08-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −4 942 | 82 453 | −5,65 | 21,00 | −103 782 | 1 731 513 | |
2019-03-27 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 553 | 86 339 | −2,87 | 20,54 | −52 439 | 1 773 403 | |
2019-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −5 228 | 88 892 | −5,55 | 20,23 | −105 762 | 1 798 285 | |
2019-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −4 437 | 94 120 | −4,50 | 20,23 | −89 761 | 1 904 048 | |
2019-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 57 725 | 57 725 | |||||
2019-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 944 | 98 557 | −2,90 | 20,23 | −59 557 | 1 993 808 | |
2019-03-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 25 951 | 101 501 | 34,35 | ||||
2019-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −1 500 | 72 548 | −2,03 | ||||
2019-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 500 | 75 550 | −1,95 | 25,36 | −38 037 | 1 915 774 |
2019-03-06 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 1 500 | 77 050 | 1,99 | 13,35 | 20 025 | 1 028 618 | |
2019-02-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 016 | 74 048 | −11,91 | ||||
2019-02-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 016 | 75 550 | −11,71 | 24,37 | −244 090 | 1 841 154 |
2019-02-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 016 | 85 566 | 13,26 | 13,35 | 133 714 | 1 142 306 | |
2019-01-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 245 | 75 550 | −4,12 | 19,52 | −63 354 | 1 475 016 |
2018-12-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 59 600 | −14,37 | ||||
2018-12-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 78 795 | −11,26 | 22,40 | −224 001 | 1 765 016 |
2018-12-04 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 88 795 | 12,69 | 11,33 | 113 300 | 1 006 047 | |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 172 | 78 152 | −3,90 | 20,61 | −65 366 | 1 610 494 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 69 600 | −12,56 | ||||
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −10 000 | 81 324 | −10,95 | 21,47 | −214 723 | 1 746 213 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 10 000 | 91 324 | 12,30 | 11,33 | 113 300 | 1 034 701 | |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −19 800 | 79 600 | −19,92 | ||||
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −8 528 | 81 324 | −9,49 | 20,85 | −177 786 | 1 695 386 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −16 784 | 89 852 | −15,74 | 20,26 | −340 098 | 1 820 689 |
2018-11-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 19 800 | 106 636 | 22,80 | 11,33 | 224 334 | 1 208 186 | |
2018-08-17 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −2 407 | 86 836 | −2,70 | 17,59 | −42 333 | 1 527 219 |
2018-07-11 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 250 | 89 243 | −3,51 | 16,46 | −53 498 | 1 469 020 |
2018-04-23 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 273 | 91 374 | −1,37 | 19,31 | −24 582 | 1 764 432 | |
2018-03-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 677 | 92 647 | −1,78 | 18,61 | −31 209 | 1 724 161 | |
2018-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −3 434 | 94 324 | −3,51 | 19,91 | −68 371 | 1 877 991 | |
2018-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −2 915 | 97 758 | −2,90 | 19,91 | −58 038 | 1 946 362 | |
2018-03-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 51 921 | 51 921 | |||||
2018-03-16 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 22 359 | 100 673 | 28,55 | ||||
2018-03-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
M - Exercise | −19 801 | 99 400 | −16,61 | ||||
2018-03-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −19 801 | 78 314 | −20,18 | 20,10 | −398 004 | 1 574 127 |
2018-03-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 19 801 | 98 115 | 25,28 | 11,33 | 224 345 | 1 111 643 | |
2017-12-05 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −6 226 | 78 314 | −7,36 | 19,67 | −122 465 | 1 540 436 |
2017-10-13 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −3 026 | 83 496 | −3,50 | 18,56 | −56 176 | 1 550 070 |
2017-06-01 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | −4 297 | 86 522 | −4,73 | 16,93 | −72 731 | 1 464 463 | |
2017-04-25 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 384 | 90 819 | −1,50 | 14,74 | −20 400 | 1 338 672 | |
2017-03-28 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 823 | 92 203 | −1,94 | 13,76 | −25 084 | 1 268 713 | |
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −3 704 | 94 026 | −3,79 | 13,75 | −50 930 | 1 292 858 | |
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 84 064 | 84 064 | |||||
2017-03-20 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 33 707 | 97 730 | 52,65 | ||||
2016-08-15 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −1 027 | 63 625 | −1,59 | 18,19 | −18 681 | 1 157 313 |
2016-07-19 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −2 297 | 64 652 | −3,43 | 17,76 | −40 795 | 1 148 220 |
2016-06-03 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
S - Sale | X | −2 297 | 66 949 | −3,32 | 16,00 | −36 752 | 1 071 184 |
2016-04-22 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 383 | 69 246 | −1,96 | 13,05 | −18 048 | 903 660 | |
2016-03-29 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 823 | 70 629 | −2,52 | 11,96 | −21 803 | 844 723 | |
2016-03-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 119 201 | 119 201 | |||||
2016-03-21 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 39 717 | 72 452 | 121,33 | ||||
2015-04-23 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
F - Taxes | −1 384 | 32 735 | −4,06 | 15,21 | −21 051 | 497 899 | |
2015-03-30 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Employee Stock Option (right to buy) |
A - Award | 58 074 | 58 074 | |||||
2015-03-30 |
|
4 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
A - Award | 19 397 | 34 119 | 131,76 | ||||
2014-06-24 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
29 444 | ||||||||
2014-06-24 | 3 | AMPH |
Amphastar Pharmaceuticals, Inc.
Common Stock |
29 444 | ||||||||
2013-10-04 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | −6 250 | 0 | −100,00 | ||||
2013-10-04 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | −15 000 | 3 750 | −80,00 | ||||
2013-10-04 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | −21 250 | 0 | −100,00 | 43,11 | −916 088 | ||
2013-10-04 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | 6 250 | 21 250 | 41,67 | 5,83 | 36 438 | 123 888 | |
2013-10-04 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | 15 000 | 15 000 | 18,87 | 283 050 | 283 050 | ||
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −36 | 12 500 | −0,29 | |||
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | X | −36 | 0 | −100,00 | 38,00 | −1 368 | |
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 36 | 36 | 10,68 | 384 | 384 | |
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −4 603 | 12 536 | −26,86 | |||
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | X | −4 603 | 0 | −100,00 | 38,00 | −174 914 | |
2013-02-05 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 4 603 | 4 603 | 10,68 | 49 160 | 49 160 | |
2013-01-28 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 611 | 17 139 | −8,59 | |||
2013-01-28 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −6 250 | 0 | −100,00 | |||
2013-01-28 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | X | −7 861 | 0 | −100,00 | 38,00 | −298 718 | |
2013-01-28 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 1 611 | 7 861 | 25,78 | 10,68 | 17 205 | 83 955 |
2013-01-28 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 6 250 | 6 250 | 10,68 | 66 750 | 66 750 | |
2012-11-09 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2012-08-17 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −12 500 | 6 250 | −66,67 | |||
2012-08-17 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | X | −12 500 | 0 | −100,00 | 35,50 | −443 750 | |
2012-08-17 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 12 500 | 12 500 | 5,83 | 72 875 | 72 875 | |
2012-07-18 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
A - Award | 30 000 | 30 000 | |||||
2012-07-18 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Stock Option (Right to Buy) |
M - Exercise | X | −4 983 | 0 | −100,00 | |||
2012-07-18 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
S - Sale | X | −4 983 | 0 | −100,00 | 32,00 | −159 456 | |
2012-07-18 |
|
4 | HITK |
HI TECH PHARMACAL CO INC
Common Stock |
M - Exercise | X | 4 983 | 4 983 | 19,95 | 99 411 | 99 411 |